Skip to main content

Table 3 Cost (USD at 2018 levels) -per averted DALY by decrease in PrEP prices and % of non-UAI users stopping Condom use on receiving PrEP

From: Cost utility analysis of HIV pre exposure prophylaxis among men who have sex with men in Israel

% non-UAI stopping condom useDecrease in PrEP pricesBEP price decrease
10%50%70%90%
0%860,319479,292288,77998,26587.5%
25%893,876500,869304,366107,86288.6%
50%929,611523,847320,964118,08289.6%
75%967,744548,366338,677128,98790.7%
  1. Notes: Assumes 80% PrEP take up by high-risk MSM,
  2. 25% PrEP take up by low-risk MSM
  3. PrEP efficacy of 86.0% (References (4, 5)
  4. Based on MOH payment schedule to HMOs for HIV/AIDS patients
  5. BEP Break Even Point (price decrease) for cost-effectiveness